SEARCH

SEARCH BY CITATION

References

  • Avidor-Reiss T., Nevo I., Levy R., Pfeuffer T. and Vogel Z. (1996) Chronic opioid treatment induces adenylyl cyclase V superactivation: involvement of Gβγ. J. Biol. Chem. 271, 2130921315.
  • Avidor-Reiss T., Nevo I., Saya D., Bayewitch M. and Vogel Z. (1997) Opiate-induced adenylyl cyclase superactivation is isozyme-specific. J. Biol. Chem. 272, 50405047.
  • Bates M. D., Senogles S. E., Bunzow J. R., Liggett S. B., Civelli O. and Caron M. G. (1991) Regulation of responsiveness at D2 dopamine receptors by receptor desensitization and adenylyl cyclase sensitization. Mol. Pharmacol. 39, 5563.
  • Bayewitch M. L., Nevo I., Avidor-Reiss T., Levy R., Simonds W. F. and Vogel Z. (2000) Alterations in detergent solubility of heterotrimeric G proteins after chronic activation of Gi/o-coupled receptors: changes in detergent solubility are in correlation with onset of adenylyl cyclase superactivation. Mol. Pharmacol. 57, 820825.
  • Boundy V. A., Chen J. and Nestler E. J. (1998) Regulation of cAMP-dependent protein kinase subunit expression in CATH.nd SH-SY5Y cells. J. Pharmacol. Exp. Ther. 286, 10581065.
  • Chen Y. B., Harry A., Li J. R., Smit M. J., Bai X., Magnusson R., Pieroni J. P., Weng G. Z. and Iyengar R. (1997) Adenylyl cyclase 6 is selectively regulated by protein kinase A phosphorylation in a region involved in Gαs stimulation. Proc. Natl Acad. Sci. USA 94, 1410014104.
  • Chern Y. (2000) Regulation of adenylyl cyclases in the central nervous system. Cell. Signal. 12, 195204.
  • Cumbay M. G. and Watts V. J. (2001) Heterologous sensitization of recombinant adenylate cyclases by activation of D2 dopamine receptors. J. Pharmacol. Exp. Ther. 297, 12011209.
  • Hacker B. M., Tomlinson J. E., Wayman G. A., Sultana R., Chan G., Villacres E., Disteche C. and Storm D. R. (1998) Cloning, chromosomal mapping, and regulatory properties of the human type 9 adenylyl cyclase (ADCY9). Genomics 50, 97104.
  • Hanoune J. and Defer N. (2001) Regulation and role of adenylyl cyclase isoforms. Ann. Rev. Pharmacol. Toxicol. 41, 145174.
  • Iwami G., Kawabe J.-I., Ebina T., Cannon P. J., Homey C. J. and Ishikawa Y. (1995) Regulation of adenylyl cyclase by protein kinase A. J. Biol. Chem. 270, 1248112484.
  • Johnston C. A., Cumbay M. G., Vortherms T. A. and Watts V. J. (2001) Adrenergic agonists induce heterologous sensitization of adenylate cyclase in NS20Y-D2L cells. FEBS Lett. 497, 8589.
  • Lane-Ladd S. B., Pineda J., Boundy V. A., Pfeuffer T., Krupinski J., Aghajanian G. K. and Nestler E. J. (1997) CREB (cAMP response element-binding protein) in the locus coeruleus: biochemical, physiological, and behavioral evidence for a role in opiate dependence. J. Neurosci. 17, 78907901.
  • Liu F.-C., Wu G.-C., Hsieh S.-T., Lai H.-L., Wang H.-F., Wang T.-W. and Chern Y. (1998) Expression of type VI adenylyl cyclase in the central nervous system: implication for a potential regulator of multiple signals in different neurotransmitter systems. FEBS Lett. 436, 9298.
  • McDermott A. M. and Sharp G. W. G. (1995) Noradrenaline induces supersensitivity of adenylyl cyclase in NG108-15 and HT29-18 cells by not in the β-cell RINm5F. Cell. Signal. 7, 277285.
  • Nestler E. J. and Aghajanian G. K. (1997) Molecular and cellular basis of addiction. Science 278, 5862.
  • Nevo I., Avidor-Reiss T., Levy R., Bayewitch M., Heldman E. and Vogel Z. (1998) Regulation of adenylyl cyclase isozymes on acute and chronic activation of inhibitory receptors. Mol. Pharmacol. 54, 419426.
  • Oki N., Takahashi S.-I., Hidaka H. and Conti M. (2000) Short term feedback regulation of cAMP in FRTL-5 thyroid cells. J. Biol. Chem. 275, 1083110837.
  • Port J. D., Hadcock J. R. and Malbon C. C. (1992) Cross-regulation between G-protein-mediated pathways: acute activation of the inhibitory pathway of adenylylcyclase reduces β2-adrenergic receptor phosphorylation and increases β-adrenergic responsiveness. J.Biol. Chem. 267, 84688472.
  • Premont R. T. (1994) Identification of adenylyl cyclases by amplification using degenerate primers. Methods Enzymol. 238, 116127.
  • Premont R. T., Chen J., Ma H.-W., Ponnapalli M. and Iyengar R. (1992) Two members of a widely expressed subfamily of hormone-stimulated adenylyl cyclases. Proc. Natl Acad. Sci. USA 89, 98099813.
  • Qi Y., Wang J. K. T., McMillina M. and Chikaraishi D. M. (1997) Characterization of a CNS cell line, CAD, in which morphological differentiation is initiated by serum deprivation. J. Neurosci. 17, 12171225.
  • Rhee M.-H., Nevo I., Avidor-Reiss T., Levy R. and Vogel Z. (2000) Differential superactivation of adenylyl cyclase isozymes after chronic activation of the CB1 cannabinoid receptor. Mol. Pharmacol. 57, 746752.
  • Rubenzik M., Varga E., Stropova D., Roeske W. R. and Yamamura H. I. (2001) Expression of α-transducin in Chinese hamster ovary cells stably transfected with the human δ-opioid receptor attenuates chronic opioid agonist-induced adenylyl cyclase superactivation. Mol. Pharmacol. 60, 10761082.
  • Schoffelmeer A. N. M., De Vries T. J., Vanderschuren L. J. M. J., Tjon G. H. K., Nestby P., Warden G. and Mulder A. H. (1997) Intermittent morphine administration induces a long-lasting synergistic effect of corticosterone on dopamine D1 receptor functioning in rat striatal GABA neurons. Synapse 25, 381388.DOI: 10.1002/(SICI)1098-2396(199704)25:4<381::AID-SYN9>3.3.CO;2-V
  • Schwede F., Maronde E., Genieser H.-G. and Jastorff B. (2000) Cyclic nucleotide analogs as biochemical tools and prospective drugs. Pharmacol. Ther. 87, 199226.
  • Sette C. and Conti M. (1996) Phosphorylation and activation of a cAMP-specific phosphodiesterase by the cAMP-dependent protein kinase. J. Biol. Chem. 271, 1652616534.
  • Sharma S. K., Klee W. A. and Nirenberg M. (1975) Dual regulation of adenylate cyclase accounts for narcotic dependence and tolerance. Proc. Natl Acad. Sci. USA 72, 30923096.
  • Suri C., Fung B. P., Tischler A. S. and Chikaraishi D. M. (1993) Catecholaminergic cell lines from the brain and adrenal glands of tyrosine hydroxylase-SV40 T-antigen transgenic mice. J. Neurosci. 13, 12801291.
  • Taussig R. and Zimmerman G. (1998) Type-specific regulation of mammalian adenylyl cyclases by G protein pathways. Adv. Second Messenger Phosphoprotein Res. 32, 8198.
  • Thomas J. M. and Hoffman B. B. (1987) Adenylate cyclase supersensitivity: a general means of cellular adaptation to inhibitory agonists? Trends Pharmacol. Sci. 8, 308311.
  • Thomas J. M. and Hoffman B. B. (1996) Isoform-specific sensitization of adenylyl cyclase activity by prior activation of inhibitory receptors: role of βγ subunits in transducing enhanced activity of the type VI isoform. Mol. Pharmacol. 49, 907914.
  • Tzavara E. T., Valjent E., Firmo C., Mas M., Beslot F., Defer N., Roques B. P., Hanoune J. and Maldonado R. (2000) Cannabinoid withdrawal is dependent upon PKA activation in the cerebellum. Eur. J. Neurosci. 12, 10381046.
  • Van Vliet B. J., Van Rijswijk A. L. C. T., Wardeh G., Mulder A. H. and Schoffelmeer A. N. M. (1993) Adaptive changes in the number of Gs- and Gi-proteins underlie adenylyl cyclase sensitization in morphine-treated rat striatal neurons. Eur. J. Pharmacol. 245, 2329.
  • Varga E. V., Stropova D., Rubenzik M., Wang M., Landsman R. S., Roeske W. R. and Yamamura H. I. (1998) Identification of adenylyl cyclase isoenzymes in CHO and B82 cells. Eur. J. Pharmacol. 348, R1R2.
  • Watts V. J. and Neve K. A. (1996) Sensitization of endogenous and recombinant adenylate cyclase by activation of D2 dopamine receptors. Mol. Pharmacol. 50, 966976.
  • Watts V. J., Vu M. N., Wiens B. L., Jovanovic V., Van Tol H. H. M. and Neve K. A. (1999) Short- and long-term heterologous sensitization of adenylate cyclase by D4 dopamine receptors. Psychopharmacology 141, 8392.
  • Watts V. J., Wiens B. L., Cumbay M. G., Vu M. N., Neve R. L. and Neve K. A. (1998) Selective activation of Gαo by D2L dopamine receptors in NS20Y neuroblastoma cells. J. Neurosci. 18, 86928699.
  • Watts V. J., Taussig R., Neve R. and Neve K. A. (2001) Dopamine D2 receptor-induced heterologous sensitization of adenylyl cyclase requires Gαs: characterization of Gαs-insensitive mutants of adenylyl cyclase V. Mol. Pharmacol. 60, 11681172.